cyc 202 has been researched along with purmorphamine in 1 studies
| Studies (cyc 202) | Trials (cyc 202) | Recent Studies (post-2010) (cyc 202) | Studies (purmorphamine) | Trials (purmorphamine) | Recent Studies (post-2010) (purmorphamine) |
|---|---|---|---|---|---|
| 979 | 7 | 393 | 89 | 0 | 68 |
| Protein | Taxonomy | cyc 202 (IC50) | purmorphamine (IC50) |
|---|---|---|---|
| Smoothened homolog | Homo sapiens (human) | 1.5 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alkanderi, S; Filby, A; Henry, C; Miles, CG; Molinari, E; Ramsbottom, SA; Saunier, S; Sayer, JA; Srivastava, S; White, K | 1 |
1 other study(ies) available for cyc 202 and purmorphamine
| Article | Year |
|---|---|
A human patient-derived cellular model of Joubert syndrome reveals ciliary defects which can be rescued with targeted therapies.
Topics: Abnormalities, Multiple; Antigens, Neoplasm; Cell Cycle Proteins; Cerebellum; Child; Child, Preschool; Cilia; Ciliopathies; Cyclin-Dependent Kinase 5; Cytoskeletal Proteins; Epithelial Cells; Eye Abnormalities; Humans; Kidney Diseases, Cystic; Kidney Failure, Chronic; Male; Morpholines; Mutation; Neoplasm Proteins; Pedigree; Polycystic Kidney Diseases; Primary Cell Culture; Purines; Retina; Roscovitine; Signal Transduction | 2017 |